v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock and additional paid-in capital:
Accumulated deficit:
Accumulated other comprehensive income (loss):
Common stock
Beginning balances at Dec. 31, 2022 $ 419,024 $ 982,306 $ (560,310) $ (2,972)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   84,442      
Exercise of stock options   2,297      
Issuance of common stock under ESPP   6,100      
Repurchase of common shares   0      
Settlement of capped calls   139      
Net income (loss) (65,384)   (65,384)    
Other comprehensive income (loss)       1,861  
Ending balances at Dec. 31, 2023 448,479 1,075,284 (625,694) (1,111)  
Common stock, beginning balance (in shares) at Dec. 31, 2022         57,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)         74
Issuance of common stock under ESPP (in shares)         255
Repurchase of common shares (in shares)         0
Shares issued for the vesting of restricted stock awards (in shares)         967
Common stock, ending balance (in shares) at Dec. 31, 2023         59,031
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   94,356      
Exercise of stock options   8,404      
Issuance of common stock under ESPP   5,855      
Repurchase of common shares   0      
Settlement of capped calls   0      
Net income (loss) (38,536)   (38,536)    
Other comprehensive income (loss)       (762)  
Ending balances at Dec. 31, 2024 $ 517,796 1,183,899 (664,230) (1,873)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)         234
Issuance of common stock under ESPP (in shares)         150
Repurchase of common shares (in shares)         0
Shares issued for the vesting of restricted stock awards (in shares)         1,313
Common stock, ending balance (in shares) at Dec. 31, 2024 60,728       60,728
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   90,059      
Exercise of stock options   547      
Issuance of common stock under ESPP   6,481      
Repurchase of common shares $ (5,000) (5,000)      
Settlement of capped calls   0      
Net income (loss) 52,008   52,008    
Other comprehensive income (loss)       (80)  
Ending balances at Dec. 31, 2025 $ 661,811 $ 1,275,986 $ (612,222) $ (1,953)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)         12
Issuance of common stock under ESPP (in shares)         95
Repurchase of common shares (in shares) (69)       (69)
Shares issued for the vesting of restricted stock awards (in shares)         1,975
Common stock, ending balance (in shares) at Dec. 31, 2025 62,741       62,741